Sardocor Corp.
Sardocor Corp.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy | dilated cardiomyopathy 3B | Recruiting | Phase 1 | 2025-02-27 | NCT06224660 | |
| Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction | cardiovascular disorder, congestive heart failure, heart disorder, heart failure, systolic heart failure | Recruiting | Phase 1 / Phase 2 | 2024-03-26 | NCT04703842 | |
| Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction | cardiovascular disorder, diastolic heart failure, heart disorder, heart failure | Recruiting | Phase 1 | 2023-09-29 | NCT06061549 |